These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11019467)

  • 1. Adverse events monitoring as a routine component of vaccine clinical trials: evidence from the WHO Vaccine Trial Registry.
    Mayans MV; Robertson SE; Duclos P
    Bull World Health Organ; 2000; 78(9):1167. PubMed ID: 11019467
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety monitoring in vaccine development and immunization.
    Lee CJ; Lee LH; Lu CH; Huang YJ; Chu ML
    Acta Paediatr Taiwan; 2006; 47(1):7-13. PubMed ID: 17016963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The inspection by the Danish Medical Products Agency of drug clinical trials].
    Jacobsen E; Stilbo I
    Ugeskr Laeger; 2003 Apr; 165(16):1656-8. PubMed ID: 12756822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring vaccine safety depends on reports from providers.
    Grabenstein JD
    J Am Pharm Assoc (Wash); 1999; 39(6):869. PubMed ID: 10609455
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety considerations for new vaccine development.
    Ellenberg SS
    Pharmacoepidemiol Drug Saf; 2001; 10(5):411-5. PubMed ID: 11802587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of the Danish Medical Products Agency in clinical trials].
    Simonsen AC
    Ugeskr Laeger; 2003 Apr; 165(16):1653-6. PubMed ID: 12756821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine adverse events: separating myth from reality.
    Kimmel SR
    Am Fam Physician; 2002 Dec; 66(11):2113-20. PubMed ID: 12484693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007.
    Niu MT; Ball R; Woo EJ; Burwen DR; Knippen M; Braun MM;
    Vaccine; 2009 Jan; 27(2):290-7. PubMed ID: 18992783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination vaccines: postlicensure safety evaluation.
    Chen RT; Pool V; Takahashi H; Weniger BG; Patel B
    Clin Infect Dis; 2001 Dec; 33 Suppl 4():S327-33. PubMed ID: 11709768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategy for surveillance of adverse drug events.
    Bright RA
    Food Drug Law J; 2007; 62(3):605-16. PubMed ID: 17915403
    [No Abstract]   [Full Text] [Related]  

  • 11. Guidelines for reporting adverse events associated with vaccine products. Division of Immunization, Bureau of Infectious Diseases, Laboratory Center for Disease Control.
    Can Commun Dis Rep; 2000 Feb; 26 Suppl 1():I-IV, 1-18. PubMed ID: 11055081
    [No Abstract]   [Full Text] [Related]  

  • 12. Human papillomavirus vaccine safety in pediatric patients: an evaluation of the Vaccine Adverse Event Reporting System.
    Borja-Hart NL; Benavides S; Christensen C
    Ann Pharmacother; 2009 Feb; 43(2):356-9. PubMed ID: 19155346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reporting adverse vaccine events.
    O'Rourke K
    J Am Vet Med Assoc; 2003 Sep; 223(6):753-4. PubMed ID: 14507079
    [No Abstract]   [Full Text] [Related]  

  • 14. Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS.
    ;
    Expert Rev Vaccines; 2009 Jun; 8(6):705-16. PubMed ID: 19485752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting possible vaccine adverse events in clinical notes of the electronic medical record.
    Hazlehurst B; Naleway A; Mullooly J
    Vaccine; 2009 Mar; 27(14):2077-83. PubMed ID: 19428833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The GCP directive--consequences for clinical drug research].
    Gluud CN
    Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving global monitoring of vaccine safety: a quantitative analysis of adverse event reports in the WHO Adverse Reactions Database.
    Letourneau M; Wells G; Walop W; Duclos P
    Vaccine; 2008 Feb; 26(9):1185-94. PubMed ID: 18243428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccinovigilance in Europe--need for timeliness, standardization and resources.
    Lankinen KS; Pastila S; Kilpi T; Nohynek H; Mäkelä PH; Olin P
    Bull World Health Organ; 2004 Nov; 82(11):828-35. PubMed ID: 15640918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collaborative improves monitoring of vaccine safety.
    Gearon CJ
    AHIP Cover; 2007; 48(5):16-8, 20, 22-4. PubMed ID: 17941571
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation and registration of adverse events in clinical drug trials in migraine.
    Tfelt-Hansen P; Bjarnason NH; Dahlöf C; Derry S; Loder E; Massiou H;
    Cephalalgia; 2008 Jul; 28(7):683-8. PubMed ID: 18498392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.